Skip to main navigation Skip to search Skip to main content

A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis

  • Paul N. Newton
  • , Hung Thai Le
  • , Quoc Tip Nguyen
  • , Jennifer M. Short
  • , Wirongrong Chierakul
  • , Adul Rajanuwong
  • , Punnee Pitisuttithum
  • , Sanchai Chasombat
  • , Benjaluck Phonrat
  • , Wirach Maek-A-Nantawat
  • , Reungsilp Teaunadi
  • , David Lalloo
  • , Nicholas J. White
  • Mahidol University
  • John Radcliffe Hospital
  • Institute of Malariology, Parasitology and Entomology
  • Sappasithiprasong Hospital
  • North East Regional Infectious Disease Hospital

Research output: Contribution to journalArticlepeer-review

105 Citations (Scopus)

Abstract

We conducted a trial of oral acetazolamide for the treatment of cryptococcal meningitis in 22 Thai adults with headache and an opening cerebrospinal fluid pressure of greater than or equal to200 mm H(2)0. The trial was terminated prematurely because patients who received acetazolamide developed significantly lower venous bicarbonate levels and higher chloride levels and had more-frequent serious adverse events than did subjects who received placebo.

Original languageEnglish
Pages (from-to)769-772
Number of pages4
JournalClinical Infectious Diseases
Volume35
Issue number6
DOIs
Publication statusPublished - 15 Sept 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis'. Together they form a unique fingerprint.

Cite this